A multi-cohort microarray study revealed that only 4.5% of 245 viable invasive breast carcinoma and 38% of 37 high-grade basal-like ductal breast carcinoma samples were NGFR positive, supporting the role of NGFR as a tumor suppressor [59]. This evidence concerns the gene NGFR and invasive breast carcinoma.